FDA Guidance and Notices, May 2025: Q-Submission Program Final Guidance and a Draft Electronic Template
If you deal with FDA through Q-Submissions, the program sponsors use to request feedback and meetings on device submissions, start with May 29. That day FDA issued final guidance on the program, along with a draft electronic submission template for Q-Submissions.
On May 6, FDA said it would expand unannounced inspections at foreign manufacturing facilities. The policy is agency-wide, and device inspections are covered. Rules setting the classification of individual device types were published in batches on May 9 and at the end of the month, most of them for diagnostic tests.
Final guidance
- Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program (May 29): Describes how the program works when sponsors ask FDA for feedback or a meeting on a device submission.
Draft guidance
- Electronic Submission Template for Medical Device Q-Submissions (May 29): Released alongside the final Q-Submission guidance, it covers the template for submitting Q-Submissions electronically.
Device classification rules
Most of these write a classification decided earlier into the regulations; they do not mean any individual product was authorized that day. "Reclassification" changes a device type's class, and "proposed" marks a proposed rule open for comment.
- May 9: Classification: Breast Milk Macronutrients Test System
- May 9: Classification: Voriconazole Test System
- May 9: Classification: Coagulation System for the Measurement of Whole Blood Viscoelastic Properties in Perioperative Patients
- May 9: Classification: Cytomegalovirus Nucleic Acid Detection Device for Congenital Cytomegalovirus Infection
- May 9: Classification: Device To Detect and Identify Microbial Nucleic Acids by Fluorescence In Situ Hybridization in Clinical Specimens
- May 9: Classification: Device To Detect and Measure Non-Microbial Analytes To Aid in the Detection and Identification of Localized Human Infections
- May 9: Classification: Device To Detect Nucleic Acids From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections and Associated Resistance Marker(s)
- May 9: Classification: DNA-Based Test To Measure Minimal Residual Disease in Hematological Malignancies
- May 9: Classification: Microbial Nucleic Acid Storage and Stabilization Device
- May 29: Classification: Plazomicin Test System
- May 29: Classification: Temporarily-Placed Urethral Opening System for Symptoms of Benign Prostatic Hyperplasia
- May 29: Classification: Inherited Nucleotide Repeat Disorder Deoxyribonucleic Acid Test
- May 29: Classification: Zika Virus Serological Reagents
- May 30: Classification: Anti-Mullerian Hormone Test System
Safety communications and other updates
- FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities (May 6): An agency-wide announcement rather than a device-specific one. It also addresses regulatory responses when a device inspection is refused or delayed.
Note: dates are FDA issue dates or Federal Register publication dates. Linked pages may now show a later version.
RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.
← All articles